Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Amino Piperidine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1950362A reveals a safer, scalable synthesis for tryptase inhibitor intermediates. Discover cost-effective manufacturing and supply chain advantages.
Novel enzymatic route for R-3-aminopiperidine dihydrochloride offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN105377831B reveals a scalable transfer hydrogenation route for high-purity pharmaceutical intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Discover advanced stereospecific synthesis of piperidine derivatives from patent CN102093260A. Enhance supply chain reliability and reduce manufacturing costs with scalable one-pot routes.
Patent CN101952252A details a tartaric acid resolution method for high-purity piperidine intermediates, offering significant cost reduction in API manufacturing and supply chain reliability.
Patent CN101977899A details a cost-effective Pd-catalyzed hydrogenation and mandelic acid resolution for high-purity piperidine intermediates, ensuring supply chain stability.
Discover the cost-effective palladium-catalyzed manufacturing method for piperidine-3-ylcarbamate intermediates. Enhance supply chain reliability and reduce production costs for diabetes drug synthesis.
Patent CN105734089A reveals enzymatic synthesis for pharmaceutical intermediates. Offers high optical purity and scalable production for global supply chains.
Patent CN108409639B details a novel chiral synthesis route eliminating resolution agents. Achieve significant cost reduction and supply reliability for cardiovascular intermediates.
Novel chemo-enzymatic route for diabetes drug intermediate offers high purity and scalable manufacturing solutions for global pharmaceutical supply chains efficiently.
Patent CN1305849C reveals a cost-effective 3-step synthesis for 3-methylaminopiperidine, eliminating noble metal catalysts and significantly improving yield for pharmaceutical manufacturing.
Novel chiral induction route for (R)-3-aminopiperidine eliminates resolution waste. Delivers high ee value and cost reduction in API manufacturing for global supply chains.
Patent CN103373953A reveals a safe, high-yield route for 3-aminopiperidine, offering cost-effective API intermediate manufacturing solutions.
Novel chiral catalytic route for (R)-3-aminopiperidine. Higher yield, lower cost, scalable production for DPP-IV inhibitors. Reliable pharmaceutical intermediates supplier.
Novel 5-step synthesis from D-Glutamic acid for DPP-IV inhibitors. High yield, mild conditions, and cost-effective industrial manufacturing process.
Patent CN121204184A reveals high-purity biocatalytic route. Enhanced scalability and cost efficiency for pharmaceutical manufacturing supply chains.
Patent CN119735541A details a mild seven-step route for high-purity piperidine derivatives offering significant supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114591219A details a water-based resolution process for S-3-aminopiperidine dihydrochloride, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103570601B details a novel synthesis route for chiral intermediates ensuring high purity and cost efficiency for global pharmaceutical supply chains.
Patent CN103319399A details a green Hoffmann rearrangement route for R-3-aminopiperidine dihydrochloride, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.